Integrative Analysis of Cancer Omics Data for Prognosis Modeling
- PMID: 31405076
- PMCID: PMC6727084
- DOI: 10.3390/genes10080604
Integrative Analysis of Cancer Omics Data for Prognosis Modeling
Abstract
Prognosis modeling plays an important role in cancer studies. With the development of omics profiling, extensive research has been conducted to search for prognostic markers for various cancer types. However, many of the existing studies share a common limitation by only focusing on a single cancer type and suffering from a lack of sufficient information. With potential molecular similarity across cancer types, one cancer type may contain information useful for the analysis of other types. The integration of multiple cancer types may facilitate information borrowing so as to more comprehensively and more accurately describe prognosis. In this study, we conduct marginal and joint integrative analysis of multiple cancer types, effectively introducing integration in the discovery process. For accommodating high dimensionality and identifying relevant markers, we adopt the advanced penalization technique which has a solid statistical ground. Gene expression data on nine cancer types from The Cancer Genome Atlas (TCGA) are analyzed, leading to biologically sensible findings that are different from the alternatives. Overall, this study provides a novel venue for cancer prognosis modeling by integrating multiple cancer types.
Keywords: integrative analysis; multiple cancer types; omics data; prognosis modeling.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.Genomics. 2016 Jun;107(6):223-30. doi: 10.1016/j.ygeno.2016.04.005. Epub 2016 Apr 30. Genomics. 2016. PMID: 27141884 Free PMC article.
-
CAS-viewer: web-based tool for splicing-guided integrative analysis of multi-omics cancer data.BMC Med Genomics. 2018 Apr 20;11(Suppl 2):25. doi: 10.1186/s12920-018-0348-8. BMC Med Genomics. 2018. PMID: 29697367 Free PMC article.
-
A Method to Identify Potential Prognostic Markers Across Distinct Tumor Types.Methods Mol Biol. 2022;2445:275-288. doi: 10.1007/978-1-0716-2071-7_17. Methods Mol Biol. 2022. PMID: 34972998
-
The Application of Bayesian Methods in Cancer Prognosis and Prediction.Cancer Genomics Proteomics. 2022 Jan-Feb;19(1):1-11. doi: 10.21873/cgp.20298. Cancer Genomics Proteomics. 2022. PMID: 34949654 Free PMC article. Review.
-
Cancer omics: from regulatory networks to clinical outcomes.Cancer Lett. 2013 Nov 1;340(2):277-83. doi: 10.1016/j.canlet.2012.11.033. Epub 2012 Nov 29. Cancer Lett. 2013. PMID: 23201140 Review.
Cited by
-
Effects and prognostic values of miR-30c-5p target genes in gastric cancer via a comprehensive analysis using bioinformatics.Sci Rep. 2021 Oct 18;11(1):20584. doi: 10.1038/s41598-021-00043-w. Sci Rep. 2021. PMID: 34663825 Free PMC article.
-
Statistics in the Genomic Era.Genes (Basel). 2020 Apr 18;11(4):443. doi: 10.3390/genes11040443. Genes (Basel). 2020. PMID: 32325634 Free PMC article.
-
Knowledge Generation with Rule Induction in Cancer Omics.Int J Mol Sci. 2019 Dec 18;21(1):18. doi: 10.3390/ijms21010018. Int J Mol Sci. 2019. PMID: 31861438 Free PMC article. Review.
References
-
- Chiu C.G., Nakamura Y., Chong K.K., Huang S.K., Kawas N.P., Triche T., Elashoff D., Kiyohara E., Irie R.F., Morton D.L., et al. Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. Clin. Chem. 2014;60:873–885. doi: 10.1373/clinchem.2013.213611. - DOI - PubMed
-
- Hoadley K.A., Yau C., Hinoue T., Wolf D.M., Lazar A.J., Drill E., Shen R., Taylor A.M., Cherniack A.D., Thorsson V., et al. Cell-of-Origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173:291–304.e6. doi: 10.1016/j.cell.2018.03.022. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources